All In MedTech

Device Trial Radar · NCT03167515

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Last checked: Nov 20, 2026Latest source record: Apr 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

95

Actual

Start

May 16, 2017

Primary completion

Nov 28, 2017

Study completion Feb 13, 2018

Sponsor

Lead sponsor
Ferndale Laboratories, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 30, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of this study is to determine the efficacy and safety of 074-6751 Lotion applied twice daily for four weeks (28 days) in clinical subjects with moderate plaque psoriasis.

Conditions

  • Plaque Psoriasis

Interventions

  • 074-6751 LotionDevice

    Apply lotion once in the morning and once in the evening daily at approximately the same time every day with 12 hours between doses. Apply the lotion only to the active psoriatic lesions, as instructed by your study doctor.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in sum of clinical signs of psoriasis (scaling, erythema, and plaque elevation) scores.Time frame: Day 29

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Site 03

    Tampa, Florida

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.